Keratin 14 Polyclonal Antibody, Purified

Pricing & Availability
Clone
Poly19053 (See other available formats)
Isotype
Rabbit Polyclonal
Poly19053_Purified_Keratin_14_Antibody_IHC_030615
Strong cytoplasmic staining of the epidermis in normal human skin tissue detected with anti-K14 (clone Poly19053).
  • Poly19053_Purified_Keratin_14_Antibody_IHC_030615
    Strong cytoplasmic staining of the epidermis in normal human skin tissue detected with anti-K14 (clone Poly19053).
Cat # Size Price Quantity Avail. Save
905301 100 µL 299,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

This antibody is effective in immunohistochemistry (IHC).

This product may contain other non-IgG subtypes.

Product Details
Instructions for Use (pdf)

Product Details

Product Information

Intended Use:

In Vitro Diagnostic (IVD). Use in immunohistochemistry (IHC) test methods only.

The polyclonal antibody Poly19053 is used for the in vitro examination of human biological samples using immunohistochemistry (IHC) methods for the qualitative identification of Keratin 14. The clinical interpretation of any staining or its absence should be complemented by morphological studies and proper controls and should be evaluated within the context of the patient's clinical history and other diagnostic tests by a qualified pathologist.

Reactivity
Human
Formulation
Phosphate-buffered solution + 0.03% Thimerosal.
Preparation
The antibody was purified by peptide affinity chromatography.
Concentration
1.0 mg/mL
Storage & Handling
When stored at ≤ -20°C, product is stable until the date shown on the label. Avoid repeated freeze-thaw cycles to prevent denaturing the antibody. If thawed and stored between 2°C and 8°C, product is stable for 24 months from the date of thaw or until the expiry date on the label, whichever comes first.
Recommended Usage

Each lot of this antibody is quality control tested by immunohistochemical staining.

The optimal working dilution should be determined for each specific assay condition.
IHC: 1:1,000 with either biotin based detection systems such as USA Ultra Streptavidin Detection (Cat. No. 929501).

Tissue Sections: Paraffin-embedded tissues, frozen tissues
Pretreatment: For optimal staining, the sections should be pretreated with an antigen unmasking solution such as Citrate Buffer Retrieval solution (Cat. No. 928502).
Incubation: 60 minutes at room temperature

Application References

(PubMed link indicates BioLegend citation)
  1. Wend P, et al. Wnt/?-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours. EMBO J., Jun 2013.
  2. Welm AL, Kim S, Welm BE, Bishop JM. MET and MYC cooperate in mammary tumorigenesis. Proc Natl Acad Sci USA 102(12):4324-9, 2005. [IHC] PubMed
  3. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M. IKKalpha controls formation of the epidermis independently of NF-kappaB. Nature 410:710-714, 2001.
  4. Yuspa SH, Kilkenny AD, Steinert PM, Roop DR. Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in-vitro. J Cell Biol 109:1207-1217, 1989.
  5. Roop DR, Cheng CK, Titterington L, Meyers CA, Stanley JR, Steinert PM, Yuspa SH. Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J Biol Chem 259:8037-8040, 1984.
  6. Liang Y. 2011. Patholog Res Int. 2011:93674. (IHC) PubMed
  7. Easter SL, et al. 2014. PLoS One. 9:113247. (IF, WB) PubMed
  8. Frew IJ, et al. 2008. Mol Cell Biol.28:4536. (IHC) PubMed
  9. Levy V, et al. 2007. FASEB J. 21:1358. (IHC) PubMed
  10. Sengupta A, et al. 2010. PLoS One. 5:12249. (IHC) PubMed
  11. Smith BA, et al. 2012. Genes Cancer.3:550. (IHC) PubMed
Product Citations
  1. Larribere L,et al. 2017. Stem Cell Reports.. 10.1016/j.stemcr.2017.08.023. PubMed
  2. Dravis C et al. 2018. Cancer cell. 34(3):466-482 . PubMed
  3. Trisno SL et al. 2018. Cell stem cell. 23(4):501-515 . PubMed
  4. Wang J, et al. 2017. Cancer Prev Res (Phila). 10:684. PubMed
  5. Reeves MQ, et al. 2018. Nat Cell Biol. 20:699. PubMed
  6. Roux LN, et al. 2018. Stem Cells. 36:1421. PubMed
  7. Price AJ, et al. 2018. Nat Commun. 9:5284. PubMed
  8. Sachs N, et al. 2019. EMBO J. 38:. PubMed
  9. Li L, et al. 2018. J Clin Invest. 128:4525. PubMed
  10. Sundberg JP, et al. 2018. PLoS One. 13:e0205775. PubMed
  11. Santoro A, et al. 2019. Cell Rep. 26:624. PubMed
  12. Song Y et al. 2018. Cell reports. 25(11):2981-2991 . PubMed
  13. Devos M, et al. 2017. J Invest Dermatol. 137:494. PubMed
  14. Yamamoto–Fukuda T, et al. 2018. J Assoc Res Otolaryngol. 19:223. PubMed
  15. Sirka OK, et al. 2018. J Cell Biol. 217:3368. PubMed
  16. Choo MK, et al. 2018. Sci Signal. 11:551. PubMed
  17. Flores A, et al. 2019. Nat Commun. 10:91. PubMed
  18. Joshi PA, et al. 2019. Nat Commun. 10:1760. PubMed
  19. Han Y et al. 2019. Cell reports. 27(3):835-846 . PubMed
  20. Ren G, et al. 2019. Sci Rep. 9:6688. PubMed
  21. Smith P, et al. 2019. Sci Rep. 9:7079. PubMed
  22. Gao Y, et al. 2019. Life Sci Alliance. 2:3. PubMed
  23. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  24. Wohlfahrt T, et al. 2019. Nature. 566:344. PubMed
  25. Norum JH, et al. 2019. Int J Cancer. web only. PubMed
  26. Castillo–Azofeifa D, et al. 2018. Development. 145. PubMed
  27. May AJ, et al. 2018. Development. 145. PubMed
  28. Stratikopoulos EE, et al. 2019. Oncogene. 38:47. PubMed
  29. Kim SJ, et al. 2019. Oncogene. 38:5942. PubMed
  30. Schipper K, et al. 2019. Nat Commun. 10:3800. PubMed
  31. Zhao C, et al. 2017. Science. 356:eaal3485. PubMed
  32. Suen AA, et al. 2018. Toxicol Pathol. 46:574. PubMed
  33. Esposito M, et al. 2019. Nat Cell Biol. 21:627. PubMed
  34. Li L, et al. 2019. Cell Stem Cell. 24:271. PubMed
  35. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  36. Narla ST et al. 2019. Am J Pathol. 190(1):108-124 . PubMed
  37. Kalan LR, et al. 2019. Cell Host Microbe. 25:641. PubMed
  38. Spurgeon ME et al. 2019. Elife. 8 pii: e50056. PubMed
  39. Hannezo E et al. 2017. Cell. 171(1):242-255 . PubMed
  40. Lee SH, et al. 2018. Cell. 173:515. PubMed
  41. Yanagi T, et al. 2018. Cancer Res. 78:6795. PubMed
  42. Florian S, et al. 2019. Proc Natl Acad Sci U S A. 116:11444. PubMed
  43. Meyer M, et al. 2019. J Cell Mol Med. 24:1774. PubMed
  44. Koyama S, et al. 2019. PLoS One. 14:e0216104. PubMed
  45. Sakamoto K, et al. 2020. Sci Rep. 0.560416667. PubMed
  46. Rosenbluth JM, et al. 2020. Nat Commun. 11:1711. PubMed
  47. Risom T, et al. 2020. J Clin Invest. 130:231. PubMed
  48. Piedrafita G, et al. 2020. Nat Commun. 11:1429. PubMed
  49. Liu C, et al. 2019. Nat Commun. 10:4589. PubMed
  50. Gordon GSD, et al. 2019. J Biomed Opt. 24:1. PubMed
  51. Cohen J, et al. 2019. J Cell Biol. 218:1390. PubMed
  52. Zhu S, et al. 2018. J Control Release. 282:156. PubMed
  53. Kashgari G, et al. 2020. Developmental Cell. 52(6):764-778. PubMed
  54. Lorenzo–Martín LF, et al. 2020. Nat Commun. 3.783333333. PubMed
  55. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  56. Böttcher J, et al. 2015. J Immunol. 195: 5066 - 5076. PubMed
  57. Welm A, et al. 2005. Proc Natl Acad Sci U S A. 102:4324-4329. PubMed
  58. Liang Y 2011. Patholog Res Int. 2011:936794. PubMed
  59. Frew I, et al. 2008. Mol Cell Biol. 28:4536-4548. PubMed
  60. Levy V, et al. 2007. FASEB J. 21:1358-1366. PubMed
  61. Sengupta A, et al. 2010. PLoS One. 5:e12249. PubMed
  62. Smith B, et al. 2012. Genes Cancer. 3:550-563. PubMed
  63. Easter S, et al. 2014. PLoS One. 9:e113247. PubMed
  64. Cheung K, et al. 2016. Proc Natl Acad Sci U S A. 113: 854 - 863. PubMed
  65. Lichtenberger B, Watt M 2016. Nat Commun. 7:10537. PubMed
  66. Nair S, et al. 2016. Nat Commun. 7:10913. PubMed
  67. Alrefai H, et al. 2016. Nat Commun. 7:11724. PubMed
  68. Dahlhoff M, et al. 2016. Development. 143: 1823 - 1831. PubMed
  69. Kriegbaum M, et al. 2016. Sci Rep. 6: 25833. PubMed
  70. Turpin J, et al. 2016. Oncogene. 10.1038/onc.2016.129. PubMed
  71. Panousopoulou E, et al. 2016. J Cell Sci. 129: 1915 - 1927. PubMed
  72. Sada A, et al. 2016. Nat Cell Biol. 18: 619-631. PubMed
  73. Annunziato S, et al. 2016. Genes Dev. 30: 1470 - 1480. PubMed
  74. Wuidart A, et al. 2016. Genes Dev. 30: 1261 - 1277. PubMed
  75. Nahidiazar L, et al. 2016. PLoS One. 11: 0158884. PubMed
  76. E Joo, I Lombaert, K Yamada 2016. J Dent Res. 95(13):1518-1527. PubMed
  77. Hasche D, et al. 2016. PLoS One. 11: 0161283. PubMed
  78. Yoo K, et al. 2016. Mol Cell Biol. 36: 2108 - 2120. PubMed
  79. Goguet-Rubio P, et al. 2016. Proc Natl Acad Sci U S A. 113: 11004 - 11009. PubMed
  80. Shatirishvili M, et al. 2016. Cell Death Dis. 7:e2461. PubMed
  81. Feinberg T, et al. 2016. Development. 143: 3956 - 3968. PubMed
  82. Goreczny G, et al. 2016. Oncogene. 10.1038/onc.2016.422. PubMed
  83. Scheele C, et al. 2017. Nature. 542:313-317. PubMed
  84. Guorui H, et al. 2017. Nat Commun. 8:14351. PubMed
  85. Tao L, et al. 2017. Nat Commun. 8:14431. PubMed
  86. Ruiz-Torres S, et al. 2020. Cell Stem Cell. 28(3):424-435.e6. PubMed
  87. Li CM, et al. 2020. Cell Reports. 33(13):108566. PubMed
  88. Lhmussaar K, et al. 2021. Cell Stem Cell. . PubMed
  89. Huang S, et al. 2021. Cell Stem Cell. . PubMed
RRID
AB_2565048 (BioLegend Cat. No. 905301)
Disclaimer

WARNINGS AND PRECAUTIONS

  1. Use appropriate personal protective equipment and safety practices per universal precautions when working with this reagent. Refer to the reagent safety data sheet.
  2. All specimens, samples and any material coming in contact with them should be considered potentially infectious and should be disposed of with proper precautions and in accordance with federal, state and local regulations.
  3. Do not use this reagent beyond the expiration date stated on the label.
  4. Do not use this reagent if it appears cloudy or if there is any change in the appearance of the reagent as these may be indication of possible deterioration.

Related FAQs

There are no FAQs for this product.
Go To Top Version: 6    Revision Date: 11.13.2020

Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account